Screening for new antidepressants with fast onset and long-lasting action

Keyphrases

• Flinders Sensitive Line Rat 100%
• Fast Onset 100%
• Newer Antidepressants 100%
• Antidepressants 66%
• High Risk 16%
• Depressed Patients 16%
• Patient's Will 16%
• Construct Validity 16%
• Drug Use 16%
• Morbidity Mortality 16%
• Early Onset 16%
• Dopamine 16%
• Serotonin 16%
• Fluoxetine 16%
• Major Depressive Disorder 16%
• Depressive Disorder 16%
• Long-term Treatment 16%
• Antidepressant Treatment 16%
• Neuronal Circuits 16%
• Prevention Strategies 16%
• Sleep Disturbance 16%
• Treatment Strategy 16%
• Cognitive Learning 16%
• Paroxetine 16%
• Reducing Activity 16%
• Return to Normal 16%
• Psychiatric Treatment 16%
• Drug Response 16%
• Predictive Validity 16%
• Desipramine 16%
• Serotonin Level 16%
• Norepinephrine Levels 16%
• Dopamine Level 16%
• Behavioral Manifestations 16%
• Relapse Risk 16%
• Premature Discontinuation 16%
• Acute Treatment 16%
• Onset of Action 16%
• Learning Difficulties 16%
• Behavioral Characteristics 16%
• Mesolimbic 16%
• Reduced Body 16%
• Diagnostic Symptom 16%
• Healthy Rats 16%
• Pharmacodynamics 16%
• Behavioral Improvement 16%
• Nefazodone 16%
• Relapse Prevention 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Antidepressant 100%
• Noradrenalin 40%
• Serotonin 40%
• Antidepressant 40%
• Disease 20%
• Symptom 20%
• Prematurity 20%
• Fluoxetine 20%
• Major Depression 20%
• Sleep Disorder 20%
• Learning Disorder 20%
• Desipramine 20%
• Nefazodone 20%
• Paroxetine 20%
• Pharmacodynamics 20%

Neuroscience

• Antidepressant 100%
• Norepinephrine 40%
• Serotonin 40%
• Antidepressant 40%
• Behavior (Neuroscience) 20%
• Major Depressive Disorder 20%
• Learning Disabilities 20%
• Face 20%
• Fluoxetine 20%
• Depression 20%
• Sleep Disorder 20%
• Paroxetine 20%
• Desipramine 20%
• Nefazodone 20%